Related references
Note: Only part of the references are listed.MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Jasper F. W. Chan et al.
JOURNAL OF INFECTION (2013)
Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
Renee W. Y. Chan et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
Raoul J. de Groot et al.
JOURNAL OF VIROLOGY (2013)
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo
Qiuwei Pan et al.
HEPATOLOGY (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells
M. Khan et al.
ANTIVIRAL RESEARCH (2011)
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections
Stephan Ludwig
BIOLOGICAL CHEMISTRY (2011)
SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis
Yanze Li et al.
GENES TO CELLS (2011)
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Laurence Josset et al.
PLOS ONE (2010)
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-α
Scot D. Henry et al.
GASTROENTEROLOGY (2006)
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin
Dale L. Barnard et al.
ANTIVIRAL RESEARCH (2006)
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen et al.
JOURNAL OF VIROLOGY (2005)
Identification of active antiviral compounds against a New York isolate of West Nile virus
JD Morrey et al.
ANTIVIRAL RESEARCH (2002)
Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro
DF Smee et al.
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY (2001)
Share Paper
